| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 05/23/2002 | CA2429106A1 Treatment of sexual dysfunction with non peptide bombesin receptor antagonists |
| 05/23/2002 | CA2428733A1 Compounds having fungicidal activity and processes to make and use same |
| 05/23/2002 | CA2427296A1 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders |
| 05/23/2002 | CA2426521A1 Treatment of sexual dysfunction using bombesin antagonist |
| 05/23/2002 | CA2424961A1 Novel coupler for use in oxidative hair dyeing |
| 05/22/2002 | EP1207154A1 Herbicidal carboxamide derivatives |
| 05/22/2002 | EP1207152A2 Pesticides |
| 05/22/2002 | EP1206505A1 Electron-driven chirality switches |
| 05/22/2002 | EP1206467A1 N-heterocyclic derivatives as nos inhibitors |
| 05/22/2002 | EP1206455A1 ALPHAvBETA3 INTEGRIN INHIBITORS |
| 05/22/2002 | EP1206454A1 NOVEL INTEGRIN ALPHAvBETA3 INHIBITORS |
| 05/22/2002 | EP1206453A2 Process for the preparation of 3,5-dichloropyridine |
| 05/22/2002 | EP1206446A1 Carboxylic acid amides, their production and their use as drugs |
| 05/22/2002 | EP1206444A1 Compounds that inhibit tryptase activity |
| 05/22/2002 | EP1206436A2 Retinoids for the treatment of emphysema |
| 05/22/2002 | EP1206427A1 Chiral ligands, transition-metal complexes thereof and uses thereof in asymmetric reactions |
| 05/22/2002 | EP0923510B1 Method for nitration of aromatic compounds |
| 05/22/2002 | EP0766676B1 Compounds for inhibiting phosphodiesterase iv |
| 05/22/2002 | CN1350540A Process for preparing amine platinum complexes |
| 05/22/2002 | CN1350530A 酰胺衍生物 Amide derivatives |
| 05/22/2002 | CN1350520A Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds |
| 05/22/2002 | CN1349965A Fatty amido substituted desmethoxy hypocrellin with fatty ring or aromatic ring and its synthesis and application |
| 05/22/2002 | CN1085204C The intermediates for preparation of 2-chloro-5-alkyl aminomethylpyridines |
| 05/21/2002 | US6392084 Method for production of organic fluorine compound |
| 05/21/2002 | US6392081 Processes for preparing pesticidal intermediates |
| 05/21/2002 | US6392051 Oxidizing a 4-phenyl-n-acyldihydropyridine |
| 05/21/2002 | US6392050 Process for preparing substituted pyridines |
| 05/21/2002 | US6392049 Nitration using nitric acid |
| 05/21/2002 | US6392048 Process for preparing carbocyclic or heterocyclic nitriles by vapor phase ammoxidation |
| 05/21/2002 | US6392046 Aids therapy |
| 05/21/2002 | US6391918 N-sulphonyl and N-sulphinyl phenylglycinamide |
| 05/21/2002 | US6391910 Opioid antagonist; analgesic |
| 05/21/2002 | US6391899 Stroke therapy; cardiovascular disorders |
| 05/21/2002 | US6391895 Nitric oxide releasing chelating agents and their therapeutic use |
| 05/21/2002 | US6391893 Anticancer agents |
| 05/21/2002 | CA2223245C Catechol diethers derivatives useful as pharmaceutical agents |
| 05/21/2002 | CA2148595C Molecule labelling using 2-hydrazinopyridine derivatives |
| 05/21/2002 | CA2059909C Alkylation of azaglycine derivatives |
| 05/16/2002 | WO2002038628A2 Substituted pyridyl amine ligands, complexes and catalysts therefrom; processes for producing polyolefins therewith |
| 05/16/2002 | WO2002038534A2 Substituted alkyldiamines as inhibitors of plasmepsin or related proteases |
| 05/16/2002 | WO2002038184A1 Oral pharmaceutical composition containing a block copolymer |
| 05/16/2002 | WO2002038106A2 Calcilytic compounds |
| 05/16/2002 | WO2002037927A2 Compounds and methods for promoting smoking cessation |
| 05/16/2002 | WO2002018339A3 Compounds useful as insecticides, compounds useful as acaricides, and processes to use and make same |
| 05/16/2002 | WO2001098291A3 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 05/16/2002 | WO2001083459A3 Uracil substituted phenyl sulfamoyl carboxamides |
| 05/16/2002 | WO2001079195A3 Pyridine and pyrazine derivatives as thrombin inhibitors |
| 05/16/2002 | WO2001046180A3 Novel derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same |
| 05/16/2002 | US20020058811 Naphthalene derivatives |
| 05/16/2002 | US20020058704 Multicomponent compositions containing chitosan and methods of preparing same |
| 05/16/2002 | US20020058652 Pharmaceutical compositions and methods for use |
| 05/16/2002 | US20020058646 Substituted pyridine compounds useful for controlling chemical synaptic transmission |
| 05/16/2002 | US20020058583 Stereospecific catalysts for polymerization of addition polymerizable monomers |
| 05/16/2002 | US20020058195 High contrast, containing novel type of nucleating agent |
| 05/16/2002 | US20020056827 Piezoelectric element and process for production thereof |
| 05/16/2002 | DE10053795A1 5-HT6 Receptor antagonist medicaments, useful for treating central nervous system disorders such as Alzheimer's disease, comprising naphthalene N-phenylsulfonamide derivatives |
| 05/16/2002 | CA2428784A1 Oral pharmaceutical composition containing a block copolymer |
| 05/16/2002 | CA2428266A1 Substituted alkyldiamines as inhibitors of plasmepsin or related proteases |
| 05/16/2002 | CA2426730A1 Calcilytic compounds |
| 05/15/2002 | EP1204668A1 Bisimidino compounds and the transitional metal complexes thereof as well as the use thereof as catalysts |
| 05/15/2002 | EP1204663A1 Novel spiro compounds |
| 05/15/2002 | EP1204657A1 Piperidine and pyrrolidine derivatives displaying neuronal activity |
| 05/15/2002 | EP1204645A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 05/15/2002 | EP1204643A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 05/15/2002 | EP1204642A1 Fungicides |
| 05/15/2002 | EP1204323A1 Fungicides |
| 05/15/2002 | EP1204322A1 Fungicides |
| 05/15/2002 | EP1071745A4 Process for synthesizing cox-2 inhibitors |
| 05/15/2002 | EP0931066B1 Method of preparing phosphodiesterase iv inhibitors |
| 05/15/2002 | EP0706513B1 Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors |
| 05/15/2002 | CN1349525A Di-aryl acid derivatives as PPAR receptor ligands |
| 05/15/2002 | CN1349519A Glucokinase activators |
| 05/15/2002 | CN1349509A Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 05/15/2002 | CN1349507A Pyridine-2,3-dicarboxylic acid diamides |
| 05/15/2002 | CN1349505A Process for preparing tribomomethylsulfonylphyridine |
| 05/15/2002 | CN1349498A Alkenyl-and alkynyl-containing metalloprotease inhibitors |
| 05/15/2002 | CN1349497A Monofluoroalkyl derivatives |
| 05/15/2002 | CN1349485A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 05/15/2002 | CN1348956A Substituted diazacycloheptane compound, medicine composite contg. same and the use thereof |
| 05/15/2002 | CN1084740C Angiogensis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 05/15/2002 | CN1084738C 1,3-di-substituted 2-nitroguanidines prepn. method |
| 05/15/2002 | CN1084736C Substituted bheterocyclic carboxamide esters, their prepn. and their use as pharmaceuticals |
| 05/15/2002 | CN1084735C Substituted pyridine-2-ones and substituted pyridine-2-thiones as biocides |
| 05/15/2002 | CN1084621C 4,4-disubstituted (cyclohexan-1-ols-monomers and related compounds |
| 05/15/2002 | CN1084619C Process for preparing medicine composition |
| 05/14/2002 | US6388094 Method for making intermediates useful in synthesis of retroviral protease inhibitors |
| 05/14/2002 | US6388086 Reacting w 3-methylpyridine with base; then epoxy compound |
| 05/14/2002 | US6388084 Antiinflammatory agents; rheumatic diseases; inflammatory bowel disorders |
| 05/14/2002 | US6388077 Spiro compounds |
| 05/14/2002 | US6388022 Polystyrene |
| 05/14/2002 | US6387949 Substituted urea compounds useful in pain management |
| 05/14/2002 | US6387934 2-Cyano-3,5-dihydroxyhex-2-enecarboxamide derivatives |
| 05/14/2002 | CA2267186C Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
| 05/14/2002 | CA2150162C New n-pyridyl carboxamides and derivatives thereof, preparation processes thereof and pharmaceutical compositions containing thereof |
| 05/14/2002 | CA2010542C Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes |
| 05/10/2002 | WO2002036565A1 Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 05/10/2002 | WO2002036555A1 Sulfamides as gamma-secretase inhibitors |
| 05/10/2002 | WO2002036554A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
| 05/10/2002 | WO2002036173A2 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| 05/10/2002 | WO2002036119A1 Δ2,-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke |